Haemorheological role of platelet aggregation and hypercoagulability in microcirculation : therapeutical approach with pentoxifylline

The pathophysiology of disturbances in platelet function and intravasal hypercoagulability in diseases with impaired microcirculation is reviewed, and related relevant experimental and clinical findings with pentoxifylline are presented. Recent studies have revealed the antithrombotic properties of...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 2(1980), 6 vom: 08., Seite 372-9
1. Verfasser: Müller, R (VerfasserIn)
Weitere Verfasser: Lebrach, F
Format: Aufsatz
Sprache:English
Veröffentlicht: 1980
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Journal Article Review Fibrinolytic Agents Theobromine OBD445WZ5P Pentoxifylline SD6QCT3TSU
LEADER 01000naa a22002652 4500
001 NLM06978292X
003 DE-627
005 20231222004627.0
007 tu
008 231222s1980 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0233.xml 
035 |a (DE-627)NLM06978292X 
035 |a (NLM)7001492 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Müller, R  |e verfasserin  |4 aut 
245 1 0 |a Haemorheological role of platelet aggregation and hypercoagulability in microcirculation  |b therapeutical approach with pentoxifylline 
264 1 |c 1980 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 16.01.1981 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a The pathophysiology of disturbances in platelet function and intravasal hypercoagulability in diseases with impaired microcirculation is reviewed, and related relevant experimental and clinical findings with pentoxifylline are presented. Recent studies have revealed the antithrombotic properties of pentoxifylline which contribute to its haemorheological profile and therapeutical efficacy 
650 4 |a Journal Article 
650 4 |a Review 
650 7 |a Fibrinolytic Agents  |2 NLM 
650 7 |a Theobromine  |2 NLM 
650 7 |a OBD445WZ5P  |2 NLM 
650 7 |a Pentoxifylline  |2 NLM 
650 7 |a SD6QCT3TSU  |2 NLM 
700 1 |a Lebrach, F  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)  |d 1995  |g 2(1980), 6 vom: 08., Seite 372-9  |w (DE-627)NLM023961570 
773 1 8 |g volume:2  |g year:1980  |g number:6  |g day:08  |g pages:372-9 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_121 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 2  |j 1980  |e 6  |b 08  |h 372-9